REMEDI Inc. (KOSDAQ:387690)

South Korea · Delayed Price · Currency is KRW

17,550

-60 (-0.34%)

At close: Sep 9, 2026

REMEDI Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Revenue	22,771	14,628	13,441	6,918
Revenue Growth	229.17%	8.83%	94.30%	-
Gross Profit	13,725	8,579	7,704	3,821
Operating Income	7,874	2,750	943.97	-2,319
Net Income	9,021	4,965	906.46	-3,659
Earnings Per Share	1409.09	777.00	141.86	-573.00
EPS Growth	-	447.72%	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
South Korea	1,421	2,449	2,404	1,751
Overseas	21,349	12,179	11,037	5,166
Total	22,771	14,628	13,441	6,918

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Investments	1,903	1,506	1,692	869.06
Total Debt	11,181	11,899	9,017	10,385
Net Cash (Debt)	-9,278	-10,393	-7,325	-9,516
Net Cash Growth	-	-	-	-
Net Cash Per Share	-1449.38	-1626.55	-1146.39	-1489.24

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Operating Cash Flow	2,369	-2,856	2,363	-3,072
Capital Expenditures	-940.07	-121.96	-87.41	-2,780
Free Cash Flow	1,429	-2,978	2,276	-5,852
Free Cash Flow Growth	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Gross Margin	60.28%	58.65%	57.31%	55.23%
Operating Margin	34.58%	18.80%	7.02%	-33.52%
Pretax Margin	34.05%	16.52%	5.52%	-52.90%
Profit Margin	39.62%	33.95%	6.74%	-52.90%
FCF Margin	6.27%	-20.36%	16.93%	-84.60%